TrialReader


Comparison of Wire Assisted Percutaneous Balloon Mitral Valvulotomy With Standard Inoue Balloon Valvulotomy

NCT06150274 — Not applicable, Completed, 20 participants, Helse Stavanger HF

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Simplifying Percutaneous Balloon Mitral Valvulotomy (PBMV) to Reduce the Burden of Mitral Stenosis in Sub-Saharan Africa.

RegistryNCT06150274, acronym CROSSVal
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, treatment
Enrollment20 (Actual)
SponsorHelse Stavanger HF (Other gov); collaborators: Haukeland University Hospital
ConditionsRheumatic Heart Disease
InterventionsPercutaneous Balloon Mitral Valvulotomy (Device)
Datesstart 2024-05-24, primary completion 2024-05-31, completion 2024-06-03, first posted 2023-11-29, last updated 2024-06-20
Locations1 site in Ethiopia

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Rheumatic Heart Disease All trials of Percutaneous Balloon Mitral Valvulotomy

-Summary

The goal of this randomised study is comparison of wire assisted balloon mitral valvulotomy to standard Inoue balloon technique on patients with rheumatic mitral stenosis. The main question it aims to answer is whether procedure time is reduced using the wire assisted method. Participants will be randomized to one of the two methods.

Expand all sections  ·  Collapse all

+Detailed description

Background: Rheumatic valvular disease, a chronic sequela of acute rheumatic fever, is a leading cause of cardiovascular mortality in developing countries. The available options of management include surgical treatment and balloon valvulotomy. Among various forms of rheumatic valvular lesions, severe mitral stenosis with favorable morphology can be successfully treated by balloon valvulotomy.

Methods: The study is a randomized controlled trial with intervention in both arms.

The objective of this study is to compare procedural time as a primary end point.

+Arms and interventions

ArmTypeInterventionsDescription
standard Inoue balloon techniqueActive comparatorDevice: Percutaneous Balloon Mitral ValvulotomyThose randomized to the standard care will undergo the procedure using the contemporary Inoue balloon system (Toray Industries, Japan), which is available in 4 sizes: 24, 26, 28 and 30 mm.
wire assisted crossingActive comparatorDevice: Percutaneous Balloon Mitral ValvulotomyThe procedure is performed on a similar fashion until atrial septal entry. Once the atrial wall is traversed, and the Mullins sheath is within the left atrium, the mitral valve is crossed with a flexible 0.032- or 0.035 in- 145 cm J-tipped wire. This step could be assisted by a steerable sheath. Once the mitral valve is crossed, the initial wire will be exchanged with a looped stiff wire (Safari or similar) to the left ventricle by use of a 5/6 f pigtail catheter. A commercially available balloon is used to perform the valvulotomy/commissurotomy procedure. Choice of balloon size is made following the formula: Balloon size = patient height (cm)/10 + 10. Fine tuning of the balloon size will be performed peri-operative based on transesophageal echo findings. Use of a separate stiff wire placed in the left atrium/pulmonary vein to ease passage through the atrial septum is left to the discretion of the operator based on the anatomical challenges faced during the procedure.
  • Percutaneous Balloon Mitral Valvulotomy (Device): Stenotic mitral valve will be dilated to open the commissures

+Outcome measures

Primary outcomes

  • Reduction in procedure duration [day 1]: procedure time in minutes

Secondary outcomes

  • procedure failure [day 1]: failed procedure after lengthy attempt

Other outcomes

  • mortality [30 days]: short and long term survival
  • mortality [3 months]: short and long term survival
  • Hospitalization for heart failure [2 year]: hospitalization for worsening heart failure
  • Procedure related neurological events [day 1]: new neurological events
  • Procedure related neurological events [30 days]: new neurological events
  • Vascular complications requiring intervention [day 1]: transfusion requiring bleeding or vascular complication requiring percutaneous or surgical intervention
  • new arrythmia [day 1]: previously non existing arrythmia registered after intervention
  • new bradyarrythmia [day 1]: new bradyarrythmia requiring device intervention

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* significant mitral stenosis
* low Wilkins score (< 10)
* mitral regurgitation grade not more than 2

Exclusion Criteria:

* high Wilkins score (>10)
* unfavourable anatomy
* presence of left appendage thrombus
* non-conclusive periprocedural trans oesophageal echocardiography imaging

+Locations (1)

FacilityCityCountryStatus
Tikur Anbessa Specialized HospitalAddis Ababa, Addis AbabaEthiopia

+Investigators

My Notes